Current Applications for Overcoming Resistance to Targeted Therapies edited by Myron R. Szewczuk, Bessi Qorri, Manpreet Sambi.

Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Szewczuk, Myron R. (Editor), Qorri, Bessi (Editor), Sambi, Manpreet (Editor)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2019.
Edition:1st ed. 2019.
Series:Resistance to Targeted Anti-Cancer Therapeutics, 20
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Introduction to the Acquisition of Resistance to Targeted Therapy
  • Targeting the Tumor Microenvironment to Overcome Resistance to Targeted Therapy
  • Current Challenges and Applications of Oncolytic Viruses in Overcoming Resistance to Therapies in Cancer
  • Novel Methods to Overcome Acquired Resistance to Immunotherapy
  • Therapies to Overcome Multidrug-Resistant Receptors
  • Overcoming Resistance to PARP Inhibition
  • Novel Methods of Overcoming HER2 Therapy Resistance in Breast Cancer
  • Emerging Novel Therapies for Overcoming Resistance to Targeted Therapies
  • Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
  • Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy
  • Index.